Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T59735 | Target Info | |||
Target Name | Interferon receptor (IFNR) | ||||
Synonyms |
Interferon receptor
Click to Show/Hide
|
||||
Target Type | Clinical trial Target | ||||
Gene Name | NO-GeName | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | GABA(A) receptor alpha-1 (GABRA1) | Successful Target | ||||
UniProt ID | GBRA1_HUMAN | |||||
Gene Name | GABRA1 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-1; GABA(A) receptor subunit alpha-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Z-100 | Drug Info | IC50 = 14 nM | [1] | ||
Co-Target Name | GABA(A) receptor alpha-3 (GABRA3) | Successful Target | ||||
UniProt ID | GBRA3_HUMAN | |||||
Gene Name | GABRA3 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-3; GABA-A receptor alpha 3; GABA(A)Gamma-aminobutyric-acid receptor alpha-3 subunit precursor receptor; GABA(A) receptor subunit alpha-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Z-100 | Drug Info | Ki = 400 nM | [2] | ||
Co-Target Name | GABA(A) receptor alpha-2 (GABRA2) | Successful Target | ||||
UniProt ID | GBRA2_HUMAN | |||||
Gene Name | GABRA2 | |||||
Synonyms |
GABRA2; GABA-A receptor alpha 2; GABA(A)Gamma-aminobutyric-acid receptor alpha-2 subunit precursor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Z-100 | Drug Info | EC50 = 737 nM | [3] | ||
Co-Target Name | GABA A receptor alpha-1/beta-2/gamma-2 (GABRA1/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA1_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA1-GABRB2-GABRG2 | |||||
Representative Drug(s) | Z-100 | Drug Info | Ki = 26.7 nM | Click to Show More | [4] | |
2 | Z-100 | Drug Info | Ki = 26.7 nM | [4] | ||
3 | Z-100 | Drug Info | IC50 = 46.3 nM | [1] | ||
4 | Z-100 | Drug Info | IC50 = 46.3 nM | [1] | ||
Co-Target Name | GABA A receptor alpha-1/beta-1/gamma-2 (GABRA1/GABRB1/GABRG2) | Co-Target | ||||
UniProt ID | GBRA1_HUMAN-GBRB1_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA1-GABRB1-GABRG2 | |||||
Representative Drug(s) | Z-100 | Drug Info | Ki = 53 nM | [5] | ||
Co-Target Name | GABA A receptor alpha-2/beta-3/gamma-2 (GABRA2/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA2_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA2-GABRB3-GABRG2 | |||||
Representative Drug(s) | Z-100 | Drug Info | Ki = 103 nM | [6] | ||
Co-Target Name | GABA A receptor alpha-2/beta-2/gamma-2 (GABRA2/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA2_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA2-GABRB2-GABRG2 | |||||
Representative Drug(s) | Z-100 | Drug Info | EC50 = 180 nM | [7] | ||
Co-Target Name | GABA A receptor alpha-3/beta-3/gamma-2 (GABRA3/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA3_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA3-GABRB3-GABRG2 | |||||
Representative Drug(s) | Z-100 | Drug Info | Ki = 246 nM | [6] | ||
Co-Target Name | GABA A receptor alpha-3/beta-2/gamma-2 (GABRA3/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA3_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA3-GABRB2-GABRG2 | |||||
Representative Drug(s) | Z-100 | Drug Info | Ki = 975 nM | [8] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | A conformational study of ligands for omega modulatory sites of GABAa receptors by NOESY NMR spectroscopy and distance geometry. Bioorg Med Chem Lett. 1997 Sep 9;7(17):2277-82. | ||||
REF 2 | Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases. Eur J Med Chem. 2019 Nov 1;181:111569. | ||||
REF 3 | Synthesis and biological evaluation of 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimdin-5(6H)-ones as functionally selective ligands of the benzodiazepine receptor site on the GABA(A) receptor. J Med Chem. 2002 Nov 7;45(23):5043-51. | ||||
REF 4 | Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach. J Med Chem. 2000 Jan 13;43(1):71-95. | ||||
REF 5 | 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore mod... J Med Chem. 2006 Apr 20;49(8):2526-33. | ||||
REF 6 | Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit. J Med Chem. 2005 Mar 10;48(5):1367-83. | ||||
REF 7 | Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new se... J Med Chem. 1997 Sep 12;40(19):3109-18. | ||||
REF 8 | Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem. 2008 Nov 27;51(22):7243-52. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.